Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberley Hockley

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Clinical Pharmacology and Therapeutics|April 1, 2019
Quantifying Preferences in Drug Benefit-Risk DecisionsTommi Tervonen, Aris Angelis, Kimberley Hockley, et al.
Clinical Drug Investigation|January 22, 2026
Discrete Choice Experiment (DCE) as a Tool to Elicit Patient Preferences in a Complex Benefit-Risk Evaluation: A Case StudyJian-Yu E, Shahrul Mt-Isa, Kimberley Hockley, et al.
Biometrical Journal. Biometrische Zeitschrift|January 27, 2015
A case study using the PrOACT-URL and BRAT frameworks for structured benefit risk assessmentRichard Nixon, Christoph Dierig, Shahrul Mt-Isa, et al.
Pharmacoepidemiology and Drug Safety|July 22, 2014
Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodologyChristine E Hallgreen, Hendrika A van den Ham, Shahrul Mt-Isa, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Clinical Pharmacology and Therapeutics|April 1, 2019
Quantifying Preferences in Drug Benefit-Risk DecisionsTommi Tervonen, Aris Angelis, Kimberley Hockley, et al.
Clinical Drug Investigation|January 22, 2026
Discrete Choice Experiment (DCE) as a Tool to Elicit Patient Preferences in a Complex Benefit-Risk Evaluation: A Case StudyJian-Yu E, Shahrul Mt-Isa, Kimberley Hockley, et al.
Biometrical Journal. Biometrische Zeitschrift|January 27, 2015
A case study using the PrOACT-URL and BRAT frameworks for structured benefit risk assessmentRichard Nixon, Christoph Dierig, Shahrul Mt-Isa, et al.
Pharmacoepidemiology and Drug Safety|July 22, 2014
Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodologyChristine E Hallgreen, Hendrika A van den Ham, Shahrul Mt-Isa, et al.
Pageof 1